TMS Co., Ltd. (TYO:4891)

Japan flag Japan · Delayed Price · Currency is JPY
142.00
+3.00 (2.16%)
Oct 31, 2025, 3:30 PM JST
2.16%
Market Cap6.46B
Revenue (ttm)n/a
Net Income (ttm)-670.00M
Shares Out45.49M
EPS (ttm)-15.91
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume295,600
Average Volume319,310
Open138.00
Previous Close139.00
Day's Range138.00 - 142.00
52-Week Range120.00 - 314.00
Beta0.18
RSI40.60
Earnings DateJan 16, 2026

About TMS Co., Ltd.

TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 18
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4891
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.